Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. Allison Feduccia, PhD is a neuropharmacologist, psychedelic researcher, and a builder of virtual and in-person communities. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS.

Safety 52

Safety Medicine Therapy Research and Development 52

MMJ Recs

MAY 9, 2024

There are multiple US states with an established state-approved medical marijuana program as well as states permitting the use of cannabinol (CBD) oil – a non-psychoactive component of cannabis – for medical purposes exclusively.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

MMJ Recs

MARCH 16, 2024

Economic Growth and Job Creation of the medical marijuana industry The medical cannabis sector serves as a catalyst for economic expansion and workforce development in regions where it’s legalized. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Project CBD

JULY 28, 2023

From 1994 to 2013, he was employed as a principal investigator at DuPont Central Research and Development. with unknown pharmacological and safety profiles.” Producing and selling psychoactive products outside the regulatory auspices of the FDA or a state-regulated cannabis program is not ethical.

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

MMJ Recs

MARCH 23, 2024

Additionally, legalization may lead to increased research opportunities into the therapeutic properties of cannabis, potentially uncovering new medical uses and treatment modalities. However, there are worries about increased cannabis use, particularly among young people, and potential impacts on mental health and road safety.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

JUNE 25, 2021

Nutt Will Drive Progression of a Pipeline of New Psychedelic Medicines, Helping to Define a Clear Development Pathway to Treat Addiction Through Psychedelic Medicines. David Nutt, has joined its executive team as Chief Research Officer. Toronto, Ontario–(Newsfile Corp. June 24, 2021) – Awakn Life Sciences Corp.

Research and Development 66

Research and Development Therapy Medicine Pets 66

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience.

Dispensary 52

Dispensary Programs Access Patients 52

Cannabis Law Report

JANUARY 12, 2022

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership in support of the implementation of Oregon’s Measure 109, the first state-approved policy to allow the regulated use of psilocybin products in a facilitated setting.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Cannabis Law Report

AUGUST 22, 2021

With decriminalization efforts underway in many other cities and states, this new training, the first of its kind in the US, could set the stage for the design and deployment of programs like it across the country. Interesting piece from Lucid news. Read the full report at .

Research and Development 105

Research and Development Decriminalization Education Safety 105

PrestoDoctor

JANUARY 30, 2024

Connection between cannabis use and psychosis The connection between cannabis use and psychosis has been a topic of much research and debate. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms. These interactions may contribute to the development of cannabis-induced psychosis.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

OCTOBER 5, 2021

The National Safety Council (NSC), America’s leading nonprofit safety advocate, released results of a survey conducted as part of an ongoing effort to assess the risks of cannabis in the workplace and the results are clear: employers must do more to educate and protect their workers.

Safety 52

Safety Research and Development Policy Education 52

Cannabis Law Report

MARCH 17, 2022

Interested in public service, policy, and continuing to build a more inclusive cannabis industry in Massachusetts? Request for Qualifications (RFQ): Multimedia Profiles of Social Equity Program Participants and Supporters. Request for Responses (RFR): External Research Review. Please share this information with your networks.

Compliance 52

Compliance Compliance Research and Development Data 52

Cannabis Law Report

JULY 20, 2021

Elliott was the Governor’s Senior Advisor on Cannabis at the Governor’s Office of Business and Economic Development. She held multiple positions in the Office of San Francisco Mayor Gavin Newsom from 2009 to 2010, including Budget Office Policy Assistant, Director of Scheduling and Deputy Board Liaison. Biographies.

Research and Development 105

Research and Development Compliance Compliance Food 105

Cannabis Law Report

SEPTEMBER 23, 2022

Going forward, MAPS will focus on advocating for psychedelic policy reform to include state funding for public education, harm reduction, and unarmed crisis response services. On the heels of the update about SB 519 was news of Governor Gavin Newsom vetoing another proposed piece of drug policy legislation sponsored by Senator Wiener.

Decriminalization 52

Decriminalization Advocacy Research and Development Education 52

SpeedWeed

FEBRUARY 19, 2021

Members share information, “develop more uniformity across state frameworks” and “assist federal, state and local jurisdictions that have approved or are weighing the legalization of cannabis.”. 18 missive to Congress, the CANNRA outlined its policy priorities, including: Reinstituting the Cole Memorandum.

Research and Development 52

Research and Development Marijuana Banking Policy 52

Cannabis Law Report

AUGUST 15, 2022

The state has introduced a new program to compensate Maine cities and towns for costs they incur when opting to permit recreational, adult-use cannabis businesses. The Office of Cannabis Policy last week announced the launch of an online portal Maine municipalities can use to obtain reimbursement for up to $20,000 of those costs.

Recreational 52

Recreational Consumption Research and Development Safety 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

United Patients Group

APRIL 11, 2023

MD programs typically last for four years and consist of coursework and clinical rotations in various medical specialties. After completing an MD program, graduates must undergo a residency program that provides hands-on training and practical experience in their chosen field.

Education 52

Education Research and Development Therapy Programs 52

Cannabis Law Report

JUNE 27, 2019

The private research university in Worcester will begin offering the program in the fall. Regulatory models, health and public safety concerns and stakeholder education and enforcement are the three online, seven-week courses to be offered for the certificate that will take two semesters to complete. Press Release.

Research and Development 40

Research and Development Education Policy Programs 40

SpeedWeed

FEBRUARY 19, 2021

Cuomo today announced 30-day amendments to the Governor’s proposal to establish a comprehensive adult-use cannabis program in New York. The grants from this program may also be used to further support the social and economic equity program. ALBANY, New York, Feb. 17, 2020 – PRESS RELEASE – Governor Andrew M.

Programs 40

Programs Legislation Decriminalization Safety 40

NORML

JANUARY 4, 2019

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. The new Congress was just sworn in yesterday, and they are not wasting any time.

Legislation 126

Legislation Clinical Trials Research and Development Access 126

Cannabis Law Report

JULY 23, 2021

The bill includes several provisions for additional research to investigate the impact of legalization on public health, driving safety, and similar areas. Research, Training and Prevention. Cannabis research has been limited up to this point due to its status as a Schedule 1 controlled substance.

Research and Development 105

Research and Development DEA Programs State Laws 105

Cannabis Law Report

MAY 18, 2022

The full program can be found here. The majority of conversations at the Medical Psychedelics House of Davos will focus on regulatory approval for these compounds, their therapeutic potential, policy, safety and efficacy, biocultural preservation, drug development pipelines, and patient access.

Research and Development 52

Research and Development Therapy Treatment Policy 52

Veriheal

APRIL 14, 2022

The European Country stands to develop a thriving domestic sector with this latest move, which was enforced on March 1 following the earlier publication of a decree in the Official Journal. Prior to the decree’s publication, France had already been busy importing cannabis products for its medical cannabis pilot program.

Cultivation 52

Cultivation Supply Chain Research and Development Programs 52

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits. The Natural Medicine Health Act: Pros and Cons.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

JANUARY 27, 2022

New York’s legislation includes a psilocybin services grant program that provides financial assistance to veterans and first responders who want to access psilocybin services. Like Oregon’s psilocybin program, Washington will issue licenses for (1) manufacturing, (2) service centers, (3) facilitators, and (4) testing.

Legalization 52

Legalization Research and Development Legislation Treatment 52

The Joint Blog

JUNE 12, 2019

For the study – titled A survey of hospice professional regarding medical cannabis practices – researchers surveyed a nationally representative sample of 310 hospice professionals (primarily nurses) from 40 states. National Institute of Health. 91% of respondents said that they endorse medical marijuana for hospice patients. .

Research and Development 55

Research and Development Marijuana Education Patients 55

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Cannabis Law Report

JUNE 11, 2021

In addition, the Associate Enforcement Counsel will assist in developing policies and proposing revisions to comply with legislative and regulatory changes with a focus on compliance and enforcement matters. ESSENTIAL FUNCTIONS AND RESPONSIBILITIES. 94G, M.G.L. 94G, M.G.L. 94G, M.G.L. Perform related duties as assigned.

Research and Development 90

Research and Development Compliance Compliance Packaging 90

SpeedWeed

AUGUST 2, 2021

Many cannabis companies are working to understand Environmental, Social and Governance (ESG) trends so that they may mitigate risks and establish compliant policies at the enterprise level. The list is long, but it is also important and cannabis operators are poised to take advantage. Growers already analyze their environmental impacts.

Research and Development 52

Research and Development Supply Chain Policy Programs 52

Cannabis Law Report

JANUARY 21, 2022

Authority on real estate development and cultivation design, holding a commercial general contractor license since 2002. Founding member of the National Cannabis Industry Association, Lifetime Investor member of the ArcView Group, and sustaining member of Students for Sensible Drug Policy (SSDP) and Americans for Safe Access (ASA).

Research and Development 52

Research and Development Education Advocacy Policy 52

Cannabis Law Report

NOVEMBER 6, 2021

In addition, the Associate Enforcement Counsel will assist in developing policies and proposing revisions to comply with legislative and regulatory changes with a focus on compliance and enforcement matters. ESSENTIAL FUNCTIONS AND RESPONSIBILITIES. 94G, M.G.L. 94G, M.G.L. 94G, M.G.L. Perform related duties as assigned. Qualifications.

Research and Development 52

Research and Development Compliance Compliance Packaging 52

Cannabis Law Report

SEPTEMBER 25, 2019

She added, “Here, we are faced with the challenge of balancing public safety concerns like robberies, which the use of body cameras are intended to deter, with individual privacy.”. Policy changes include: New Licenses. Social Consumption Pilot Program. We depend on a good relationship with law enforcement. Hoffman said.

Marijuana 40

Marijuana Safety Programs Retail 40

The Cannigma

MAY 21, 2021

Today, Max Simon is the founder and CEO of Green Flower , a cannabis education company that offers training programs for employees for some of the biggest companies in the industry, online courses for people who want to work in cannabis, and programs in partnerships with 10 colleges and universities across the United States.

Education 130

Education Programs Research and Development Cannabis 130

Cannabis Law Report

MARCH 19, 2020

This advisory provides an overview of key regulatory activity and priorities that should be on the radar of any company engaged in the development or sale of products that contain CBD. In the absence of federal action, states have developed their own regulatory schemes. FDA submitted this report last week, as is discussed below.

CBD 45

CBD Research and Development Seed-To-Sale Data 45

SpeedWeed

JULY 19, 2021

“Virginia is committed to legalizing cannabis the right way—by learning from other states, by listening to public health and safety experts and by centering social equity,” Northam said. ” Information about each of the boards and the Governor’s appointments can be found below.

Legalization 52

Legalization Research and Development Safety Legislation 52